REFRACTORY
Clinical trials for REFRACTORY explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY trials appear
Sign up with your email to follow new studies for REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for refractory lymphoma: Genotype-Guided cocktail targets resistant cancer
Disease control Not yet recruitingThis study tests a personalized treatment for people with a rare and aggressive blood cancer called peripheral T-cell lymphoma (PTCL) that did not respond to initial chemotherapy. Doctors will use genetic testing of the tumor to select a combination of drugs, including an experim…
Matched conditions: REFRACTORY
Phase: PHASE1, PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 26, 2026 05:51 UTC
-
New hope for rare blood disorder: daratumumab trial targets refractory aplastic anemia
Disease control Not yet recruitingThis study tests a drug called daratumumab in people with aplastic anemia that hasn't improved with standard treatments. The goal is to see if it is safe and can help the body make more blood cells. About 37 participants will receive multiple doses, and researchers will check for…
Matched conditions: REFRACTORY
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New study checks if a stomach tube helps severe constipation in the long run
Symptom relief Not yet recruitingThis study follows 80 adults who had a procedure called percutaneous endoscopic caecostomy (PEC) for severe chronic constipation that didn't get better with standard treatments. Researchers will check long-term quality of life and how well the procedure is tolerated by phone inte…
Matched conditions: REFRACTORY
Sponsor: Nantes University Hospital • Aim: Symptom relief
Last updated May 06, 2026 16:03 UTC